Publications by authors named "Bharat Madan"

Article Synopsis
  • * Yeast cells exhibit a wider size range compared to mammalian cells, which makes it challenging to accurately determine single-cell gates during FACS.
  • * The report investigates different gating options for yeast display and proposes an optimized flow cytometry method to enhance the selection of single yeast cells, leading to improved results in yeast display studies.
View Article and Find Full Text PDF

In vitro antibody evolution is a powerful technique for improving monoclonal antibodies. This can be achieved by generating artificial diversity on an antibody template, which can be done using different in vitro diversification techniques. The resulting libraries consist of single- or multimutant variants of a defined antibody template that are screened for improved function using antibody display.

View Article and Find Full Text PDF

Antibodies consist of unique variable heavy (V) and variable light (V) chains, and both are required to fully characterize an antibody. Methods to detect paired heavy and light chain variable regions (V:V) using high-throughput sequencing (HTS) have recently enabled large-scale analysis of complete functional antibody responses. Here, we describe an HTS computational pipeline to analyze paired V:V antibody sequences and obtain a comprehensive profile of immune diversity landscapes, including gene usage, antibody isotypes, and clonal lineage analysis.

View Article and Find Full Text PDF

Antibody repertoire sequencing and display library screening are powerful approaches for antibody discovery and engineering that can connect DNA sequence with antibody function. Antibody display and screening studies have made a tremendous impact on immunology and biotechnology over the last decade, accelerated by technological advances in high-throughput DNA sequencing techniques. Indeed, bioinformatic analysis of antibody DNA library data has now taken a central role in modern antibody drug discovery, and is also critical for many ongoing studies of human immune development.

View Article and Find Full Text PDF

Antibody functional screening studies and next-generation sequencing require careful processing and interpretation of sequence data for optimal results. Here, we provide a detailed protocol for the functional analysis of antibody gene data, including antibody repertoire quantification and functional mapping of high-throughput screening data based on enrichment ratio values, which are a simple way to determine the enrichment of each sequenced antibody after sorting a display library against desired antigens. This protocol enables a user to apply a set of simple yet powerful bioinformatic tools for high-throughput analysis and interpretation of antibody data that is especially well suited for display library screening and for antibody discovery applications.

View Article and Find Full Text PDF

The HIV-1 fusion peptide (FP) represents a promising vaccine target, but global FP sequence diversity among circulating strains has limited anti-FP antibodies to ~60% neutralization breadth. Here we evolve the FP-targeting antibody VRC34.01 in vitro to enhance FP-neutralization using site saturation mutagenesis and yeast display.

View Article and Find Full Text PDF

Adoptive immune therapies based on the transfer of antigen-specific T cells have been used successfully to treat various cancers and viral infections, but improved techniques are needed to identify optimally protective human T cell receptors (TCRs). Here we present a high-throughput approach to the identification of natively paired human TCRα and TCRβ (TCRα:β) genes encoding heterodimeric TCRs that recognize specific peptide antigens bound to major histocompatibility complex molecules (pMHCs). We first captured and cloned TCRα:β genes from individual cells, ensuring fidelity using a suppression PCR.

View Article and Find Full Text PDF

Next-generation DNA sequencing (NGS) of human antibody repertoires has been extensively implemented to discover novel antibody drugs, to analyze B-cell developmental features, and to investigate antibody responses to infectious diseases and vaccination. Because the antibody repertoire encoded by human B cells is highly diverse, NGS analyses of antibody genes have provided a new window into understanding antibody responses for basic immunology, biopharmaceutical drug discovery, and immunotherapy. However, many antibody discovery protocols analyze the heavy and light chains separately due to the short-read nature of most NGS technologies, whereas paired heavy and light chain data are required for complete antibody characterization.

View Article and Find Full Text PDF
Article Synopsis
  • Continuous emergence of SARS-CoV-2 variants poses challenges for vaccine effectiveness, diagnostics, and treatments, raising concerns about a potential new highly transmissible and fatal betacoronavirus.
  • The study utilized yeast display technology and next-generation sequencing to analyze the specificity of antibodies from two convalescent donors, focusing on their responses to SARS-CoV-2 variants and other betacoronaviruses.
  • Most antibodies from the patients were found to be non-neutralizing, and the degree of somatic hypermutation varied significantly between the individuals, providing insights that could inform strategies against emerging coronavirus threats.
View Article and Find Full Text PDF

The monoclonal antibody CIS43 targets the Plasmodium falciparum circumsporozoite protein (PfCSP) and prevents malaria infection in humans for up to 9 mo following a single intravenous administration. To enhance the potency and clinical utility of CIS43, we used iterative site-saturation mutagenesis and DNA shuffling to screen precise gene-variant yeast display libraries for improved PfCSP antigen recognition. We identified several mutations that improved recognition, predominately in framework regions, and combined these to produce a panel of antibody variants.

View Article and Find Full Text PDF
Article Synopsis
  • * Traditional methods for detecting antibodies targeting the aquaporin-4 (AQP4) protein are laborious and time-consuming, involving single B-cell sorting and multiple complex steps.
  • * The study compares two faster screening methods—cell-based biopanning and FACS screening—that successfully enhance the discovery of AQP4-binding antibodies from yeast libraries, potentially expediting therapeutic research and analysis.
View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic has led to the emergence of multiple SARS-CoV-2 variants that show increased resistance to vaccines and treatments, prompting the need for better tools to study these variants.
  • Researchers developed biotin-labeled molecular probes targeting different parts of the SARS-CoV-2 spike protein to help isolate neutralizing antibodies and monitor vaccine effectiveness.
  • The study provides a collection of these probes, which can identify immune responses and aid in the characterization of neutralizing antibodies, with constructs made available for wider research use.
View Article and Find Full Text PDF

Functional analyses of the T cell receptor (TCR) landscape can reveal critical information about protection from disease and molecular responses to vaccines. However, it has proven difficult to combine advanced next-generation sequencing technologies with methods to decode the peptide-major histocompatibility complex (pMHC) specificity of individual TCRs. We developed a new high-throughput approach to enable repertoire-scale functional evaluations of natively paired TCRs.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic has led to the evolution of SARS-CoV-2, resulting in various variants that can resist vaccines and treatments, particularly due to mutations in the virus's spike protein.
  • The researchers designed biotin-labeled molecular probes for these spike variants, allowing for easier isolation of neutralizing antibodies and assessment of vaccine effectiveness.
  • They validated these probes with yeast displaying virus-binding antibodies and made their findings available through Addgene to help further research on immune responses and antibody characterization against COVID-19 variants.
View Article and Find Full Text PDF
Article Synopsis
  • Antiviral monoclonal antibody (mAb) discovery aims to develop effective treatments for viral infections, but traditional methods are often inefficient due to the high affinity of antibodies not always translating to neutralizing activity.
  • Researchers explored screening for anti-SARS-CoV-2 mAbs at lower pH levels, specifically pH 4.5, and found that neutralizing antibodies were more effectively enriched at this acidity compared to physiological pH (7.4).
  • A new antibody, LP5, was identified that targets a key area of the SARS-CoV-2 virus, demonstrating the potential of low pH screening to enhance the discovery of effective antiviral antibodies.
View Article and Find Full Text PDF

Understanding mechanisms of protective antibody recognition can inform vaccine and therapeutic strategies against SARS-CoV-2. We report a monoclonal antibody, 910-30, targeting the SARS-CoV-2 receptor-binding site for ACE2 as a member of a public antibody response encoded by IGHV3-53/IGHV3-66 genes. Sequence and structural analyses of 910-30 and related antibodies explore how class recognition features correlate with SARS-CoV-2 neutralization.

View Article and Find Full Text PDF

An effective vaccine for respiratory syncytial virus (RSV) is an unrealized public health goal. A single dose of the prefusion-stabilized fusion (F) glycoprotein subunit vaccine (DS-Cav1) substantially increases serum-neutralizing activity in healthy adults. We sought to determine whether DS-Cav1 vaccination induces a repertoire mirroring the pre-existing diversity from natural infection or whether antibody lineages targeting specific epitopes predominate.

View Article and Find Full Text PDF
Article Synopsis
  • The resurgence of the Zika virus has been linked to health issues like Guillain-Barré syndrome and birth defects, highlighting the importance of understanding immune responses to the virus.
  • Researchers used advanced antibody screening methods to study the anti-Zika antibodies in individuals who recovered from the infection, examining their properties and interactions.
  • Findings revealed significant variations in antibody development based on individual characteristics, providing valuable insights into how the immune system responds to Zika and paving the way for better vaccine designs against this and similar viruses.
View Article and Find Full Text PDF

Vaccine-based elicitation of broadly neutralizing antibodies holds great promise for preventing HIV-1 transmission. However, the key biophysical markers of improved antibody recognition remain uncertain in the diverse landscape of potential antibody mutation pathways, and a more complete understanding of anti-HIV-1 fusion peptide (FP) antibody development will accelerate rational vaccine designs. Here we survey the mutational landscape of the vaccine-elicited anti-FP antibody, vFP16.

View Article and Find Full Text PDF
Article Synopsis
  • A new antibody, 910-30, has been identified that targets the SARS-CoV-2 ACE2 receptor binding site, part of a public antibody response encoded by specific IGHV genes.
  • Structural analyses via Cryo-EM show how 910-30 interacts with the SARS-CoV-2 spike trimer, revealing its ability to bind and disassemble the spike protein.
  • The study highlights important sequence and structural signatures for neutralization in the IGHV3-53/3-66 antibody class, with a notable prevalence of antibody precursors found in healthy human B cells.
View Article and Find Full Text PDF

Biotin-labeled molecular probes, comprising specific regions of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike, would be helpful in the isolation and characterization of antibodies targeting this recently emerged pathogen. Here, we design constructs incorporating an N-terminal purification tag, a site-specific protease-cleavage site, the probe region of interest, and a C-terminal sequence targeted by biotin ligase. Probe regions include full-length spike ectodomain as well as various subregions, and we also design mutants that eliminate recognition of the angiotensin-converting enzyme 2 (ACE2) receptor.

View Article and Find Full Text PDF
Article Synopsis
  • - Researchers developed biotin-labeled molecular probes from regions of the SARS-CoV-2 spike protein to help isolate and study antibodies against the virus.
  • - The design involved using a purification tag and a targeted protease-cleavage site, yielding different amounts of biotin-labeled probes, with specific structures confirmed through cryo-electron microscopy.
  • - Funding for the project came from multiple sources, including the National Institute of Allergy and Infectious Diseases and various grants, while no conflicts of interest were reported by the authors.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers created biotin-labeled molecular probes targeting specific regions of the SARS-CoV-2 spike protein to help isolate and study antibodies against the virus.
  • These probes included various designs, such as full-length spike regions and modifications to prevent ACE2 receptor recognition, yielding different amounts during production.
  • The resulting probes were tested for their ability to bind antibodies and were structurally analyzed using advanced imaging techniques, showcasing the effectiveness of combining structural design with purification methods.
View Article and Find Full Text PDF

Yeast display has become an important tool for modern biotechnology with many advantages for eukaryotic protein engineering. Antibody-based peptide interactions are often used to quantify yeast surface expression (e.g.

View Article and Find Full Text PDF

Emulsion-based techniques have dramatically advanced our understanding of single-cell biology and complex single-cell features over the past two decades. Most approaches for precise single cell isolation rely on microfluidics, which has proven highly effective but requires substantial investment in equipment and expertise that can be difficult to access for researchers that specialize in other areas of bioengineering and molecular biotechnology. Inspired by the robust droplet generation technologies in modern flow cytometry instrumentation, here we established a new platform for high-throughput isolation of single cells within droplets of tunable sizes by combining flow focusing with ultrasonic vibration for rapid and effective droplet formation.

View Article and Find Full Text PDF